References
- Aaron SD, TNFα antagonists for acute exacerbations of COPD: a randomized double-blind controlled trial. Thorax 2013; 68:142–148. doi: 10.1136/thoraxjnl-2012-202432.
- Gross NJ. The COPD Pipeline COPD 2010; 7:154–156.
- Gross NJ. The COPD Pipeline XIX COPD; 9:649–650.
- Snell G, Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. Eur Respir J 2012; 39:1326–1333.
- Slebos D-J, Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema. Chest 2012; 142:574–582.
- Pascal LML, A new class of bronchodilator improves lung function in COPD: A trial withGSK961081. ERJ Express February 21, 2013 as doi: 10.1183/09031936.00165712
- Gross NJ. The COPD Pipeline IX. COPD 2011; 8:136–138.
- Watz H, Inhaled pan-selectin antagonist bimosiamose attenuates airway inflammation in COPD. Pulm Pharmacol Therap 2013; 26:265–270.
- Jackson L, Interim adjusted estimates of seasonal influenza vaccine effectiveness—United States. February 2013 MMWR 2013; 62:119–123.